Rhabdomyosarcoma masquerading as acute leukemia

Pediatric Blood and Cancer

Volumn 52, Issue 2, 2009, Pages 286-287

  Shinkoda, Yuichi ^a   Nagatoshi, Yoshihisa ^a   Fukano, Reiji ^a   Nishiyama, Kenichi ^a   Okamura, Jun ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Bone marrow involvement; Immunohistochemistry; Rhabdomyosarcoma

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; CEFMETAZOLE; DESMIN; LYMPHOCYTE ANTIGEN; MEMBRANE ANTIGEN; MYOGLOBIN;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BONE MARROW METASTASIS; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; TREATMENT RESPONSE; ACUTE DISEASE; BONE MARROW CELL; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; PATHOLOGY;

ACUTE DISEASE; BONE MARROW CELLS; BONE MARROW EXAMINATION; CHILD; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; MALE; RHABDOMYOSARCOMA;

EID: 59449095620     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21783     Document Type: Article

References (10)

1. Breneman JC, Lyden E, Pappo AS. et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-A report from the intergroup rhabdomyosarcoma study IV. J Clin Oncol 2003;21:78-84.
2. Ruymann FB, Newton WA, Ragab AH, et al. Bone marrow metastasis at diagnosis in children and adolescents with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study. Cancer 1984;82:349-353.
3. Carli M, Colombatti R, Oberlin O, et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol 2004;22:4735-4742.
4. Etcubanas E, Peiper S, Stass S, et al. Rhabdomyosarcoma, presenting as disseminated malignancy from an unknown primary site:Aretrospective study of ten pediatric cases. Med Pediatr Oncol 1989;17:39-44.
5. Moritake H, Ikuno Y, Tasaka H, et al. Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma. Bone Marrow Transplant 1998;21:725-726.
6. Varma N, Karmakar T, Ravi K, et al. Bone marrow involvement embryonal rhabdomyosarcoma. Indian J Pediatr 1993;60:316-317.
7. Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 1993;5:230-235.
8. Davis RJ, D'Cruz CM, Lovell MA, et al. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994;54:2869-2872.
9. Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the children's oncology group. J Clin Oncol 2002;20:2672-2679.
10. Brunning RD, Matutes E, Borowitz M, et al. Acute leukaemias of ambiguous lineage. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours, Pathology 2001. pp 106-107.